Melissa Dykstra - Worthington Steel Vice Relations
| WS Stock | 27.87 0.99 3.68% |
Executive
Melissa Dykstra is Vice Relations of Worthington Steel
| Address | 100 West Old Wilson Bridge Road, Columbus, OH, United States, 43085 |
| Phone | 614 840 3462 |
| Web | https://www.worthingtonsteel.com |
Worthington Steel Management Efficiency
The company has Return on Asset (ROA) of 0.0677 % which means that for every $100 of assets, it generated a profit of $0.0677. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1368 %, which means that it produced $0.1368 on every 100 dollars invested by current stockholders. Worthington Steel's management efficiency ratios could be used to measure how well Worthington Steel manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Worthington Steel's Return On Tangible Assets are comparatively stable compared to the past year. Return On Capital Employed is likely to gain to 0.19 in 2025, whereas Return On Assets are likely to drop 0.09 in 2025. At this time, Worthington Steel's Return On Tangible Assets are comparatively stable compared to the past year. Fixed Asset Turnover is likely to gain to 8.01 in 2025, whereas Total Assets are likely to drop slightly above 1.9 B in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ray MBA | Tscan Therapeutics | N/A | |
| Brendan Eckelman | Inhibrx | 46 | |
| Andrew Murphy | Regeneron Pharmaceuticals | 66 | |
| Zoran JD | Tscan Therapeutics | 54 | |
| Robert Durian | Alliant Energy Corp | 53 | |
| Ann Hargraves | Tscan Therapeutics | N/A | |
| Brain Hague | Middlesex Water | 52 | |
| Amy Cralam | Alliant Energy Corp | N/A | |
| Justin McCue | Tscan Therapeutics | N/A | |
| Patrice Gilooly | Regeneron Pharmaceuticals | N/A | |
| Christina Chan | Regeneron Pharmaceuticals | N/A | |
| Dylan Syse | Alliant Energy Corp | 39 | |
| Gerald Underwood | Regeneron Pharmaceuticals | N/A | |
| Shrikanta MD | Tscan Therapeutics | N/A | |
| Cagan Gurer | Tscan Therapeutics | N/A | |
| Susan Gille | Alliant Energy Corp | N/A | |
| Bob McCowan | Regeneron Pharmaceuticals | N/A | |
| Debora MD | Tscan Therapeutics | 48 | |
| Heather Savelle | Tscan Therapeutics | N/A | |
| Charbel PharmD | Inhibrx | N/A | |
| Melissa Lozner | Regeneron Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0677 |
Worthington Steel Leadership Team
Elected by the shareholders, the Worthington Steel's board of directors comprises two types of representatives: Worthington Steel inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Worthington. The board's role is to monitor Worthington Steel's management team and ensure that shareholders' interests are well served. Worthington Steel's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Worthington Steel's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey Klingler, Executive COO | ||
| Nikki Ballinger, Vice Resources | ||
| Jeffrey MD, Executive COO | ||
| Bill Wertz, VP Officer | ||
| John Blystone, Executive Chairman | ||
| Michaune Tillman, VP Counsel | ||
| Clifford Larivey, President Processing | ||
| Joseph Heuer, Interim Counsel | ||
| Steven Witt, Corporate Controller | ||
| Geoffrey Gilmore, President CEO | ||
| Timothy Adams, VP CFO | ||
| Melissa Dykstra, Vice Relations |
Worthington Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Worthington Steel a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0677 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.5 B | ||||
| Shares Outstanding | 50.75 M | ||||
| Shares Owned By Insiders | 36.05 % | ||||
| Shares Owned By Institutions | 50.23 % | ||||
| Number Of Shares Shorted | 1.17 M | ||||
| Price To Book | 1.35 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Worthington Stock Analysis
When running Worthington Steel's price analysis, check to measure Worthington Steel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Worthington Steel is operating at the current time. Most of Worthington Steel's value examination focuses on studying past and present price action to predict the probability of Worthington Steel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Worthington Steel's price. Additionally, you may evaluate how the addition of Worthington Steel to your portfolios can decrease your overall portfolio volatility.